Cannabis and Cancer Treatment: Scientific Facts, Urban Myths and Dangerous Misconceptions
In this article
Patients and relatives understandably seek hope amid helplessness. Unfortunately, when that search shifts from evidence-based medicine to uncontrolled online misinformation, dangerous consequences can follow. Recent social-media stories claiming “I beat cancer with cannabis” are the latest example.
Prepared with the seriousness of an oncology clinic, this report examines cannabis (Cannabis sativa), its role in cancer biology, potential benefits in palliative care and dangerous interactions, especially with modern immunotherapy.
1. The Current Debate: Anatomy of “Miracle Recovery” Claims
Recently, Dr. Dilek İnan’s claim to have defeated multiple myeloma (bone marrow cancer), a deadly cancer, using cannabis alone attracted attention. She presents herself as an “Oncology Professor,” although official records reportedly do not show that title. Scientific examination reveals:
- The Expertise Issue: Oncology specialization requires years of specific training and examinations after medical school. Investigations indicate the person lacks this qualification.
- The Disease’s Nature: Multiple myeloma is complex, requiring stem cell transplantation and smart drugs such as proteasome inhibitors. A “complete cure” within 4 months from a plant product alone is unprecedented in hematological oncology literature and requires biological explanation.
- Evidence Value: Anecdotes are not medical evidence. Without a scientific case report, unreported treatments, diagnostic accuracy or spontaneous remission cannot be verified.
2. Cannabis at the Molecular Level: What Does It Do?
Understanding cannabis requires knowing the biological network called the “Endocannabinoid System” (ECS) . It maintains balance (homeostasis) using cannabinoids produced by the body.
Cannabis substances bind to these specific sites:
- CB1 Receptors: Mainly in the brain, spinal cord and nervous system. Pain, memory and appetite control.
- CB2 Receptors: In immune cells (leukocytes, spleen) and peripheral tissues. Inflammation control.
The plant contains over 100 phytocannabinoids; the most important are:
- THC (Tetrahydrocannabinol): Strongly binds CB1, causing psychoactive effects (“getting high”), increased appetite and analgesia.
- CBD (Cannabidiol): Not psychoactive. Does not bind CB1/CB2 directly, but regulates system tone. Has anxiety-relieving and anti-inflammatory effects.
3. Does It Treat Cancer? Myths and Facts
Patients’ greatest misconception is mistaking laboratory data for human treatment. The scientific facts:
| URBAN MYTH | SCIENTIFIC FACT |
|---|---|
| “Cannabis oil kills cancer cells and destroys tumors.” | For cannabis treating human cancer, there is no proven clinical trial (Phase 3). NCI and ACS clearly reject this. |
| “It has been proven to kill cancer in the laboratory.” | True, it can kill cells in a Petri dish (in vitro). However, bleach also kills cancer in a Petri dish. This does not make it a safe, effective human medicine. |
| “Drug companies are hiding the miracle.” | On the contrary, companies already produce and sell isolated, standardized cannabis medicines such as dronabinol and Epidiolex. They manage symptoms, not cancer. |
4. Accepted Medical Roles: Symptom Management (Palliative Care)
Although cannabis does not cure cancer, it has an approved role in managing disease or treatment side effects. FDA-approved uses include:
- DRONABINOL / NABILONE Preventing severe chemotherapy-induced nausea and vomiting resistant to standard drugs.
- NABIXIMOLS (Sativex) In some countries (Canada, Europe), used alongside opioids for cancer pain.
- APPETITE STIMULATION To stimulate appetite in cachexia (wasting) associated with AIDS and advanced cancer.
5. Deadly Risks: “Natural” Does Not Mean Harmless
Cannabis poses vital risks, especially during modern cancer treatments. The greatest danger is interaction with recent years’ “miracle treatment,” immunotherapy.
Immunotherapy (pembrolizumab, nivolumab, etc.) “presses the accelerator” of immunity against cancer. Cannabis is a potent immunosuppressive agent.
Mechanism: Cannabis suppresses T cells and macrophages through CB2. Stimulating immunity with medicine while putting it to sleep with cannabis causes treatment failure.
Other Toxic Interactions
- Liver Enzymes (CYP450): Cannabis may block or accelerate liver enzymes breaking down chemotherapy, such as taxanes and irinotecan. Drug levels may become toxic or ineffective.
- Cardiovascular Risk: THC increases heart rate and may alter blood pressure, posing risks with cardiac problems.
- Fungal Infection: Unregulated street cannabis often contains Aspergillus fungus, capable of causing fatal pneumonia in immunocompromised (neutropenic) patients.
Scientific References and Further Reading
- National Academies Report: The National Academies of Sciences, Engineering, and Medicine. "The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence." Washington, DC: The National Academies Press; 2017.
- Immunotherapy Study: Bar-Sela G, et al. "Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome." Cancers (Basel). 2020;12(9):2447.
- Clinical Review: Kramer JL. "Medical marijuana for cancer." CA: A Cancer Journal for Clinicians. 2015;65(2):109-122.
- NCI PDQ: National Cancer Institute. "Cannabis and Cannabinoids (PDQ®)–Health Professional Version." 2024.
Sources
The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research.
The National Academies of Sciences, Engineering, and Medicine, 12 January 2017.
2. Joan L. Kramer MD.
Medical marijuana for cancer.
CA Cancer J Clin 2015;65: 109–122. © 2014 American Cancer Society.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.
Moving Forward in the Light of Knowledge
Dear patients and relatives, cancer is difficult, and grasping every fragment of hope is natural. But oncology advances through evidence, not miracles.
As in the example of Dr. Dilek İnan, unregulated advice outside expertise without scientific grounding may cause not just financial loss but irretrievable losses of time and health.
Our Recommendation Is Clear: